Trials / Conditions / Metastatic Kidney Carcinoma

Metastatic Kidney Carcinoma

10 registered clinical trials studyying Metastatic Kidney Carcinoma — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	CARE1 Pragmatic Clinical Trial NCT06364631	Gustave Roussy, Cancer Campus, Grand Paris	Phase 3
Completed	18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases NCT04752267	University of Southern California	EARLY_Phase 1
Completed	Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer NCT03473730	M.D. Anderson Cancer Center	EARLY_Phase 1
Terminated	Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizuma NCT03050060	University of Washington	Phase 2
Completed	Sitravatinib and Nivolumab in Treating Patients With Advanced or Metastatic Kidney Cancer NCT03015740	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Active Not Recruiting	Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Co NCT02713269	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney NCT02210117	M.D. Anderson Cancer Center	EARLY_Phase 1
Completed	Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or M NCT01835158	National Cancer Institute (NCI)	Phase 2
Terminated	Akt Inhibitor MK2206 or Everolimus in Treating Patients With Refractory Kidney Cancer NCT01239342	National Cancer Institute (NCI)	Phase 2
Active Not Recruiting	Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer NCT01038778	National Cancer Institute (NCI)	Phase 1 / Phase 2